关于miR-335-5p靶向调控MAPK10的表达促进结直肠癌进展的初步探讨
Preliminary Exploration of miR-335-5p Targeting MAPK10 to Promote the Progression of Colorectal Cancer
DOI: 10.12677/acm.2025.151244, PDF,   
作者: 覃 凯, 黄婉英, 陈 罡:广西医科大学第一附属医院病理科,广西 南宁;张 旭, 唐瑞雪:山东第一医科大学第一附属医院(山东省千佛山医院),山东省医药卫生临床病理学重点实验室,山东省肺癌研究所,山东省肾脏病研究所,山东 济南
关键词: 结直肠癌丝裂原活化蛋白激酶10miR-335-5p逆转录定量聚合酶链反应双荧光素酶实验Colorectal Cancer MAPK10 miR-335-5p Reverse Transcription Quantitative Polymerase Chain Reaction Dual-Luciferase Reporter Assay
摘要: 目的:探究丝裂原活化蛋白激酶10 (mitogen-activated protein kinase 10, MAPK10)和miR-335-5p在结直肠癌(colorectal cancer, CRC)中的表达及其两者之间的靶向结合关系。方法:本研究通过TCGA数据库分析CRC与正常结直肠组织中MAPK10和miR-335-5p的转录水平表达差异,并在SW480和Caco2细胞系中提取RNA进行逆转录定量聚合酶链反应。此外,采用双荧光素酶实验验证miR-335-5p与MAPK10的靶向结合关系。结果:TCGA数据分析显示,CRC组织中MAPK10显著低表达(P < 0.05),miR-335-5p显著高表达(P < 0.001),且二者表达呈负相关(R = −0.246, P < 0.001)。细胞系实验验证了MAPK10低表达和miR-335-5p高表达的现象。双荧光素酶实验显示miR-335-5p与MAPK10的3'非翻译区存在显著结合(P < 0.05)。结论:miR-335-5p通过与MAPK10的3'UTR结合抑制其表达,提示其在CRC中的潜在调控作用。
Abstract: Objective: To investigate the expression of mitogen-activated protein kinase 10 (MAPK10) and miR-335-5p in colorectal cancer (CRC) and their targeted binding relationship. Methods: In this study, the transcriptional level expression differences of MAPK10 and miR-335-5p between CRC and normal colorectal tissues were analyzed through the TCGA database. RNA was extracted from SW480 and Caco2 cell lines for reverse transcription quantitative polymerase chain reaction (RT-qPCR). Additionally, a dual-luciferase reporter assay was employed to verify the targeted binding relationship between miR-335-5p and MAPK10. Results: TCGA data analysis revealed that MAPK10 was significantly downregulated in CRC tissues (P < 0.05), while miR-335-5p was significantly upregulated (P < 0.001), and their expressions were negatively correlated (R = −0.246, P < 0.001). Cell line experiments confirmed the phenomena of low MAPK10 expression and high miR-335-5p expression. The dual-luciferase reporter assay demonstrated significant binding between miR-335-5p and the 3'untranslated region (3'UTR) of MAPK10 (P < 0.05). Conclusion: miR-335-5p inhibits the expression of MAPK10 by binding to its 3'UTR, suggesting its potential regulatory role in CRC.
文章引用:覃凯, 张旭, 黄婉英, 陈罡, 唐瑞雪. 关于miR-335-5p靶向调控MAPK10的表达促进结直肠癌进展的初步探讨[J]. 临床医学进展, 2025, 15(1): 1832-1841. https://doi.org/10.12677/acm.2025.151244

参考文献

[1] Siegel, R.L., Giaquinto, A.N. and Jemal, A. (2024) Cancer Statistics, 2024. CA: A Cancer Journal for Clinicians, 74, 12-49. [Google Scholar] [CrossRef] [PubMed]
[2] Mohammad, N.M.A.B., Shahril, M.R., Shahar, S., Fenech, M. and Sharif, R. (2022) Association between Diet-Related Behaviour and Risk of Colorectal Cancer: A Scoping Review. Journal of Cancer Prevention, 27, 208-220. [Google Scholar] [CrossRef] [PubMed]
[3] Shah, S.C. and Itzkowitz, S.H. (2022) Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology, 162, 715-730.e3. [Google Scholar] [CrossRef] [PubMed]
[4] Myrhøj, T., Blsgaard, M.L., Bernstein, I., Svendsen, L.B., Søndergaard, J.O. and Bulow, S. (1997) Hereditary Non-Polyposis Colorectal Cancer: Clinical Features and Survival Results from the Danish HNPCC Register. Scandinavian Journal of Gastroenterology, 32, 572-576. [Google Scholar] [CrossRef] [PubMed]
[5] Hermelink, R., Leitzmann, M.F., Markozannes, G., Tsilidis, K., Pukrop, T., Berger, F., et al. (2022) Sedentary Behavior and Cancer—An Umbrella Review and Meta-Analysis. European Journal of Epidemiology, 37, 447-460. [Google Scholar] [CrossRef] [PubMed]
[6] Cheng, C., Zhang, Z., Wang, J., Wang, C., Liu, T., Yang, C., et al. (2024) CircPGM5 Regulates Foxo3a Phosphorylation via MiR-21-5p/MAPK10 Axis to Inhibit Bladder Cancer Progression. Cellular Signalling, 121, Article ID: 111297. [Google Scholar] [CrossRef] [PubMed]
[7] Tsai, Y., Huang, C., Hsueh, Y., Fan, Y., Fong, Y., Huang, S., et al. (2021) Genetic Variants in MAPK10 Modify Renal Cell Carcinoma Susceptibility and Clinical Outcomes. Life Sciences, 275, Article ID: 119396. [Google Scholar] [CrossRef] [PubMed]
[8] Liu, F., Deng, Y., Zhao, Y., Li, Z., Gao, J., Zhang, Y., et al. (2022) Time Series RNA-Seq Analysis Identifies MAPK10 as a Critical Gene in Diabetes Mellitus-Induced Atrial Fibrillation in Mice. Journal of Molecular and Cellular Cardiology, 168, 70-82. [Google Scholar] [CrossRef] [PubMed]
[9] Zhang, X., Zhang, H., Fan, C., Hildesjö, C., Shen, B. and Sun, X. (2022) Loss of CHGA Protein as a Potential Biomarker for Colon Cancer Diagnosis: A Study on Biomarker Discovery by Machine Learning and Confirmation by Immunohistochemistry in Colorectal Cancer Tissue Microarrays. Cancers, 14, Article 2664. [Google Scholar] [CrossRef] [PubMed]
[10] Gao, Y., Wang, Y., Wang, X., Zhao, C., Wang, F., Du, J., et al. (2021) miR-335-5p Suppresses Gastric Cancer Progression by Targeting MAPK10. Cancer Cell International, 21, Article No. 71. [Google Scholar] [CrossRef] [PubMed]
[11] Messaritakis, I., Psaroudaki, E., Vogiatzoglou, K., Sfakianaki, M., Topalis, P., Iliopoulos, I., et al. (2023) Unraveling the Role of Molecular Profiling in Predicting Treatment Response in Stage III Colorectal Cancer Patients: Insights from the IDEA International Study. Cancers, 15, Article 4819. [Google Scholar] [CrossRef] [PubMed]
[12] Qiao, B., Wang, Q., Zhao, Y. and Wu, J. (2020) miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma. Reproductive Sciences, 27, 380-388. [Google Scholar] [CrossRef] [PubMed]
[13] Dai, F., Zhang, Y. and Chen, Y. (2014) Involvement of miR-29b Signaling in the Sensitivity to Chemotherapy in Patients with Ovarian Carcinoma. Human Pathology, 45, 1285-1293. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, X., Xiao, H., Wu, D., Zhang, D. and Zhang, Z. (2020) miR-335-5p Regulates Cell Cycle and Metastasis in Lung Adenocarcinoma by Targeting CCNB2. OncoTargets and Therapy, 13, 6255-6263. [Google Scholar] [CrossRef] [PubMed]
[15] Zhang, S., Liu, Y., Wang, M., Ponikwicka-Tyszko, D., Ma, W., Krentowska, A., et al. (2023) Role and Mechanism of miR-335-5p in the Pathogenesis and Treatment of Polycystic Ovary Syndrome. Translational Research, 252, 64-78. [Google Scholar] [CrossRef] [PubMed]
[16] Kamdar, R.D., Harrington, B.S., Attar, E., Korrapati, S., Shetty, J., Zhao, Y., et al. (2023) NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells. International Journal of Molecular Sciences, 24, Article 7826. [Google Scholar] [CrossRef] [PubMed]
[17] Wang, J., He, Z., Xu, J., Chen, P. and Jiang, J. (2021) Long Noncoding RNA LINC00941 Promotes Pancreatic Cancer Progression by Competitively Binding miR-335-5p to Regulate ROCK1-Mediated LIMK1/Cofilin-1 Signaling. Cell Death & Disease, 12, Article No. 36. [Google Scholar] [CrossRef] [PubMed]
[18] Nie, Y., Zhu, X., Bu, N., Jiang, Y., Su, Y., Pan, K., et al. (2022) Circ_0064288 Acts as an Oncogene of Hepatocellular Carcinoma Cells by Inhibiting miR-335-5p Expression and Promoting ROCK1 Expression. BMC Cancer, 22, Article No. 265. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, D. and Yang, N. (2019) MiR-335-5p Inhibits Cell Proliferation, Migration and Invasion in Colorectal Cancer through Down-Regulating LDHB. Journal of B.U.ON.: Official Journal of the Balkan Union of Oncology, 24, 1128-1136.
[20] Bengtsson, M., Hemberg, M., Rorsman, P. and Ståhlberg, A. (2008) Quantification of mRNA in Single Cells and Modelling of RT-qPCR Induced Noise. BMC Molecular Biology, 9, Article No. 63. [Google Scholar] [CrossRef] [PubMed]
[21] Arya, A.K., Singh, P., Saikia, U.N., Sachdeva, N., Dahiya, D., Behera, A., et al. (2019) Dysregulated Mitogen-Activated Protein Kinase Pathway Mediated Cell Cycle Disruption in Sporadic Parathyroid Tumors. Journal of Endocrinological Investigation, 43, 247-253. [Google Scholar] [CrossRef] [PubMed]
[22] Li, P., Wang, D., Yang, X., Liu, C., Li, X., Zhang, X., et al. (2024) Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification. Molecules, 29, Article 1901. [Google Scholar] [CrossRef] [PubMed]
[23] Yu, C., Ying, J., Yu, K., Shen, W. and Jiang, M. (2022) Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating cul4b Expression through miR-335-5p. Cancer Biotherapy and Radiopharmaceuticals, 37, 73-83. [Google Scholar] [CrossRef] [PubMed]
[24] Subramanian, C., McCallister, R. and Cohen, M.S. (2023) Multi-genomic Analysis of 260 Adrenocortical Cancer Patient Tumors Identifies Novel Network BIRC5-hsa-miR-335-5p-PAX8-AS1 Strongly Associated with Poor Survival. Surgery, 173, 43-51. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, X., Jin, S., Liu, J. and Xu, X. (2023) miR-223-3p Overexpressed Adipose Mesenchymal Stem Cell-Derived Exosomes Promote Wound Healing via Targeting MAPK10. Acta Histochemica, 125, Article ID: 152102. [Google Scholar] [CrossRef] [PubMed]
[26] Wei, T., Qian, N., Yang, W., Yang, Y., Liu, J., Hao, W., et al. (2022) Construction of a Novel circRNA/miRNA/mRNA Regulatory Network to Explore the Potential Pathogenesis of Wilson’s Disease. Frontiers in Pharmacology, 13, Article 905513. [Google Scholar] [CrossRef] [PubMed]
[27] Liang, B. and Wu, Y. (2023) Hsa-miR-26a-5p Improves OSCC Sensitivity to Ferroptosis by Inhibiting SLC7A11. Archives of Oral Biology, 156, Article ID: 105807. [Google Scholar] [CrossRef] [PubMed]
[28] Yang, X. and Sun, P. (2023) Circ_0088212 Targeting miR-576-5p/FKBP1A Axis Inhibits Osteosarcoma Progression. Annals of Clinical and Laboratory Science, 53, 548-561.
[29] Zhao, Y., Ye, G., Wang, Y. and Luo, D. (2022) miR-4461 Inhibits Tumorigenesis of Renal Cell Carcinoma by Targeting PPP1R3C. Cancer Biotherapy and Radiopharmaceuticals, 37, 503-514. [Google Scholar] [CrossRef] [PubMed]
[30] Feng, H., Deng, Z., Peng, W., Wei, X., Liu, J. and Wang, T. (2023) Circular RNA EPHA3 Suppresses Progression and Metastasis in Prostate Cancer through the miR-513a-3p/BMP2 Axis. Journal of Translational Medicine, 21, Article No. 288. [Google Scholar] [CrossRef] [PubMed]
[31] Cao, S., Yin, Y., Hu, H., Hong, S., He, W., Lv, W., et al. (2023) CircGLIS3 Inhibits Thyroid Cancer Invasion and Metastasis through miR-146b-3p/AIF1L Axis. Cellular Oncology, 46, 1777-1789. [Google Scholar] [CrossRef] [PubMed]
[32] Li, L., Gao, J., Li, J. and Wang, J. (2022) miR-711 Regulates Gastric Cancer Progression by Targeting CD44. Cancer Biomarkers, 35, 71-81. [Google Scholar] [CrossRef] [PubMed]
[33] Wei, B., Wang, Z., Lian, Q., Chi, B. and Ma, S. (2022) Hsa_circ_0139402 Promotes Bladder Cancer Progression by Regulating Hsa-miR-326/PAX8 Signaling. Disease Markers, 2022, Article ID: 9899548. [Google Scholar] [CrossRef] [PubMed]